Rural Health Information Hub Latest News

Impact of COVID-19 on Dental Practices

The Health Policy Institute (HPI) is conducting a bi-weekly survey of dental providers across the country to gauge the impact of COVID-19 on dental practices. According to the April 6th survey, 29.4% of PA dental practices are closed and not seeing emergency patients during the COVID-19 pandemic. Additionally, 57.2% of PA dental offices are not able to pay their staff at all during this time. A recording of “How is COVID-19 Impacting the Dental Care Sector” is available at the link below and discusses the data.

Click here for the webinar recording.
Click here for more information.
Click here for Pennsylvania-specific information.

Listen: Pandemic Stresses Already Fragile Rural Health Care Systems

Kaiser Health News (KHN) Midwest correspondent Lauren Weber joined WAMU’s “1A” show with guest host Sasha-Ann Simons to talk about the unique challenges rural health care providers face amid the coronavirus pandemic — even before their communities get overrun with a surge of COVID-19 cases.

Weber has reported on how the suspension of elective surgery and other procedures amid the pandemic has threatened the financial survival of the country’s rural hospitals — and how hospital executives don’t feel the first round of federal bailout relief money was enough. She also has written about the front-line fight at a rural Louisiana hospital that forecasts what the pandemic will look like when it hits the rest of rural America.

Listen to the story here.

COVID-19 Outreach and Enrollment News

From the Pennsylvania Association of Community Health Centers (PACHC)

Income and Eligibility for Health Insurance

The Coronavirus Aid, Relief, and Economic Security Act (CARES Act) signed into law on March 27 provided for payments of up to $1200 for every adult and $500 per dependent child. This Stimulus payment does not count as income for Medicaid/CHIP or APTC determinations. It should also not be reported on any application for assistance.

Regular Unemployment is always counted as income. The extension of unemployment of up to 39 weeks and the expansion unemployment to new populations is counted as income. The additional $600/week supplemental unemployment benefit ends July 31, 2020. This benefit does not count toward Medicaid/CHIP but DOES COUNT toward income for Marketplace Coverage and APTC eligibility.

While the Federal government has not issued a special enrollment period or opened the marketplace due to the Pandemic, consumers who have lost coverage may qualify for a special enrollment period. Special Enrollment Period Reference Guide

For more information, visits PACHC’s COVID-19 page.

Emergency SNAP Benefit Distribution to Begin Today, Local Feeding Programs Available in Pennsylvania

Pennsylvania Governor Tom Wolf announced that the Pennsylvania Department of Human Services (DHS) will begin an emergency Supplemental Nutrition Assistance Program (SNAP) benefit issuance today in line with the federal government’s interpretation of the Families First Coronavirus Response Act. Payments include a supplemental increase for both March and April and will continue to be issued for current SNAP households through April 29. DHS is also advising Pennsylvanians in need of food assistance of local supports that can help meet essential needs during the public health crisis

DHS received approval from the US Department of Agriculture’s (USDA) Food and Nutrition Service (FNS) to issue emergency payments that will allow DHS to increase a household’s currently monthly payment up to the maximum benefit amount for each household size. DHS had requested authorization to issue an additional benefit equal to a household’s monthly payment to all SNAP households and was denied.

Individuals and families in need of assistance should contact their local food bank through Feeding PA or Hunger-Free PA to find a food pantry or other distribution site in their community. The United Way of Pennsylvania and the 211 program can also connect people and families to local resources that can help during the public health crisis.

 

PLCB Begins Limited Curbside Pickup

The Pennsylvania Liquor Control Board (PLCB) today began accepting orders by phone for curbside pickup at 176 locations. Phone orders can be placed between 9 a.m. and 1 p.m., or until reaching a store’s maximum order capacity each day. Curbside pickups will be scheduled from 9 a.m. to 6 p.m. within a few days of order placement. Callers will be guided through each store’s unique inventory. There is a limit of six bottles per order, and credit cards are the only accepted form of payment. At pickup, customers will be required to present identification before the order is delivered.

The PLCB website lists the stores offering curbside pickup. PLCB anticipates expanding the service at more locations in the future. The PLCB website, FineWineAndGoodSpirits.com, is also increasing order capacity.

 

USDA’s New “Buy Fresh” Program to Purchase $100M Per Month in Fresh Produce

USDA is launching a new “Buy Fresh” program to purchase $100 million per month in fresh produce from regional and local distributors whose workforce has been significantly impacted by the closure of restaurants, hotels, and other food service entities. USDA also will buy similar quantities of dairy products and meat. The program is expected to continue for six months.

An informational webinar for interested participants will be held at 2 p.m. EDT on Tuesday, April 21, 2020, to provide an overview of the program and instructions for submitting offers. Register in advance for this webinar here. If you are unable to participate in the webinar, a recording will be available.

You can email questions to USDAFoodBoxDistributionProgram@usda.gov.

States Slowing Down the Most During the COVID-19 Pandemic – WalletHub Study

With many industries in the U.S. ground to a halt because of the coronavirus social distancing restrictions, the personal-finance website WalletHub today released its report on the States Slowing Down the Most During the COVID-19 Pandemic, as well as accompanying videos.

In order to find out which states are slowing down most during the COVID-19 pandemic, WalletHub used Google data to compare the 50 states across six key metrics. Each metric measures the percentage point increase or decrease in visits to various types of places due to coronavirus. Below, you can see highlights from the report, along with a WalletHub Q&A.

States Slowing Down the Most

States Slowing Down the Least

1. Hawaii 41. West Virginia
2. New York 42. Tennessee
3. New Jersey 43. Indiana
4. Vermont 44. Ohio
5. Nevada 45. Alabama
6. Florida 46. Iowa
7. California 47. Kentucky
8. Montana 48. Arkansas
9. Michigan 49. Kansas
10. Massachusetts 50. Nebraska

To view the full report and your state’s rank, please visit:
https://wallethub.com/edu/states-slowing-down-the-most-during-the-covid-19-pandemic/73432/

Trump Administration Champions Reporting of COVID-19 Clinical Trial Data through Quality Payment Program, Announces New Clinical Trials Improvement Activity

Improved availability of data key to driving improvement in patient care and development of innovative practices

The Centers for Medicare & Medicaid Services (CMS) is encouraging clinicians who participate in the Quality Payment Program (QPP), such as physicians, physician assistants, nurse practitioners, and others, to contribute to scientific research and evidence to fight the Coronavirus Disease 2019 (COVID-19) pandemic. Clinicians may now earn credit in the Merit-based Incentive Payment System (MIPS), a performance-based track of QPP that incentivizes quality and value, for participation in a clinical trial and reporting clinical information by attesting to the new COVID-19 Clinical Trials improvement activity. This action will provide vital data to help drive improvement in patient care and develop innovative best practices to manage the spread of COVID-19 within communities.

“The best scientific and medical minds in the world are working night and day to find treatments to combat Coronavirus,” said CMS Administrator Seema Verma. “But without solid data, their efforts are liable to run up against a brick wall. At the direction of President Trump, CMS is supporting efforts of researchers to obtain solid, actionable data to accelerate the development of new treatments and our understanding of the coronavirus.  Today’s action encourages clinicians to report data that will help us monitor the spread of the virus, find innovative medical solutions, and unleash scientific discovery as we seek to overcome this terrible disease.”

In order to receive credit for the new MIPS COVID-19 Clinical Trials improvement activity, clinicians must attest that they participate in a COVID-19 clinical trial utilizing a drug or biological product to treat a patient with a COVID-19 infection and report their findings through a clinical data repository or clinical data registry for the duration of their study.

The new improvement activity provides flexibility in the type of clinical trial, which could include the traditional double-blind placebo-controlled trial to an adaptive or pragmatic design that flexes to workflow and clinical practice. It also carries a high weight from a scoring perspective. This means that clinicians who report this activity will automatically earn half of the total credit needed to earn a maximum score in the MIPS improvement activities performance category, which counts as 15 percent of the MIPS final score.

For example, clinical trials could include those conducted by the National Institute of Health (NIH). Clinicians could also report through a clinical data repository, such as Oracle’s COVID-19 Therapeutic Learning System. Oracle has developed and donated a system to the U.S. government that allows clinicians and patients at no cost to record the effectiveness of promising COVID-19 drug therapies. Having clinicians use an open source data tool to submit their findings will bring the results of their research to the forefront of healthcare much faster, leading to improvements in care delivery and the ability to treat COVID-19 patients.

This action, along with the unprecedented regulatory flexibilities recently introduced, is just one part of the agency’s efforts to address the COVID-19 pandemic. CMS, in coordination with the White House Coronavirus Task Force, remains committed to  reducing regulator burden and supporting clinicians, stakeholders, and the health care community to identify unique solutions that enhance care for patients and further mitigate the spread of the virus.

This action, and earlier CMS actions in response to the COVID-19 virus, are part of the ongoing White House Task Force efforts. To keep up with the important work the Task Force is doing in response to COVID-19 click here www.coronavirus.gov.  For information specific to CMS, please visit the Current Emergencies Website.

To view a database of privately and publicly funded clinical studies currently being conducted on corona virus visit:  https://clinicaltrials.gov/